Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last 4,373 GBp
Change Today -119.50 / -2.66%
Volume 3.4M
AZN On Other Exchanges
New York
As of 11:35 AM 05/29/15 All times are local (Market data is delayed by at least 15 minutes).

Transactions by ASTRAZENECA PLC (AZN) in the last 6 months

Announced 03/2/15
Corridor Pharmaceuticals, Inc.

AstraZeneca PLC (LSE:AZN) acquired Corridor Pharmaceuticals, Inc. from Acidophil, LLC, MedImmune Ventures, Inc. and other investors in 2014.

AZN's price was unchanged after the transaction was announced on 03/2/15.
Investor / Buyer
AstraZeneca PLC
Creditor / Lender
Acidophil, LLC
Domain Associates, L.L.C.
Domain Partners VI, L.P.
MedImmune Ventures, Inc.
NewSpring Capital
Osage Partners LLC
Announced 02/24/15
10.00M for Laboratorios Rontag S.A.

Pharma San Isidro acquired Laboratorios Rontag S.A. from AstraZeneca PLC (LSE:AZN) for approximately ARS 10 million on February 24, 2015. The value of the transaction shall be payable in installments. The agreement comprises the transfer of all brands and registers.

AZN's price was unchanged after the transaction was announced on 02/24/15.
Investor / Buyer
Pharma San Isidro SA
Creditor / Lender
AstraZeneca PLC
Announced 12/19/14
502.00M for Moderna Therapeutics, Inc.
Private Placement

Moderna LLC announced that it will receive $502,168,634 in funding on December 19, 2014. The company will issue series E preferred units in the transaction. The company will issue securities pursuant to exemption provided under Regulation D. As of January 5, 2015, the company received $446,069,409 from 43 investors including new investors Viking Global Investors LP, Invus, RA Capital Management, and Wellington Management Company, LLP. The transaction included participation ...
Read More

AZN's price was unchanged after the transaction was announced on 12/19/14.
Investor / Buyer
Alexion Pharmaceuticals, Inc.
AstraZeneca PLC
RA Capital Management, LLC
The Invus Group, LLC
Viking Global Investors L.P.
Wellington Management Group LLP

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AZN:LN 4,372.50 GBp -119.50

AZN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
BASF SE €84.35 EUR -1.89
Biogen Inc $396.99 USD -3.11
Celgene Corp $114.44 USD -0.49
Eli Lilly & Co $78.90 USD +2.49
Valeant Pharmaceuticals International Inc C$296.44 CAD -4.04
View Industry Companies

Industry Analysis


Industry Average

Valuation AZN Industry Range
Price/Earnings 68.0x
Price/Sales 3.4x
Price/Book 5.1x
Price/Cash Flow 68.0x
TEV/Sales 3.4x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ASTRAZENECA PLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at